Guerbet Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
David Hale
Algemeen directeur
€1.5m
Totale compensatie
| Percentage CEO-salaris | 31.7% |
| Dienstverband CEO | 4.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 4.8yrs |
| Gemiddelde ambtstermijn bestuur | 7.5yrs |
Recente managementupdates
Recent updates
Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%
Nov 16
Is Guerbet (EPA:GBT) Using Too Much Debt?
Apr 27Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce
Feb 29Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture
Feb 11Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch
Jan 15The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence
Jul 22Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price
Jul 27Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report
Mar 28Is Guerbet (EPA:GBT) A Risky Investment?
Oct 25The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence
Sep 23Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?
May 27We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt
May 04Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?
Apr 05Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Mar 19What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?
Mar 01When Should You Buy Guerbet SA (EPA:GBT)?
Feb 10
How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 28Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate
Jan 13Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?
Dec 23We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential
Dec 11Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?
Nov 27Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €33m |
| Mar 31 2024 | n/a | n/a | €28m |
| Dec 31 2023 | €1m | €470k | €24m |
| Sep 30 2023 | n/a | n/a | -€9m |
| Jun 30 2023 | n/a | n/a | -€42m |
| Mar 31 2023 | n/a | n/a | -€42m |
| Dec 31 2022 | €1m | €470k | -€41m |
| Sep 30 2022 | n/a | n/a | -€14m |
| Jun 30 2022 | n/a | n/a | €13m |
| Mar 31 2022 | n/a | n/a | €23m |
| Dec 31 2021 | €2m | €470k | €33m |
| Sep 30 2021 | n/a | n/a | €33m |
| Jun 30 2021 | n/a | n/a | €33m |
| Mar 31 2021 | n/a | n/a | €26m |
| Dec 31 2020 | €933k | €470k | €18m |
Compensatie versus markt: De totale vergoeding ($USD 1.55M ) David } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de French markt ($USD 552.07K ).
Compensatie versus inkomsten: De vergoeding van David is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
David Hale (56 yo)
4.8yrs
Tenure
€1,481,777
Compensatie
Mr. David Hale served as Independent Director of Orpea SA since July 28, 2022 until January 2024. He has been Chief Executive Officer of Guerbet SA since January 1, 2020 and serves as its MD & GM. Mr. Hale...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, MD & GM | 4.8yrs | €1.48m | geen gegevens | |
| Chief Pharmacist | 4.8yrs | €11.50k | geen gegevens | |
| CFO and Senior VP of Business Development & Licensing | 5.6yrs | geen gegevens | geen gegevens | |
| Senior VP of Technical Operations & Interim Chief Pharmacist | 3.8yrs | geen gegevens | geen gegevens | |
| Director of Legal Affairs | 8.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Public Affairs & Corporate Communications | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Human Resources | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Interventional Imaging | 3.8yrs | geen gegevens | geen gegevens | |
| Senior VP of R&D | 7.2yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Diagnostic Imaging | 4.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Commercial Operations - Asia-Pacific | 4.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Commercial Operations - Americas & EMEA | 4.8yrs | geen gegevens | geen gegevens |
4.8yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van GBT wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Honorary Chairman | no data | €18.96k | 54.99% € 182.4m | |
| Chairman of the Board | less than a year | geen gegevens | geen gegevens | |
| Non-Independent Director | 11.5yrs | €27.60k | geen gegevens | |
| Non-Independent Director | 10.5yrs | €27.60k | geen gegevens | |
| Independent Director | 10.5yrs | €109.68k | geen gegevens | |
| Non-Independent Director | 9.5yrs | €27.60k | geen gegevens | |
| Non-Independent Director | 8.5yrs | €26.40k | geen gegevens | |
| Non-Independent Director | 7.5yrs | €27.60k | geen gegevens | |
| Employee Director | 4.1yrs | geen gegevens | geen gegevens | |
| Employee Director | 3.7yrs | geen gegevens | geen gegevens | |
| Non-Independent Director | 3.5yrs | €20.40k | geen gegevens | |
| Non-Independent Director | 2.5yrs | €25.20k | geen gegevens |
7.5yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van GBT wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.5 jaar).